Science ❯Pharmacology ❯Drug Development
Long-term Effects Generic Drugs Varenicline Studies Non-Opioid Medications GLP-1 Agonists ADRIANA Phase II Trials
The α2B-adrenoceptor blocker moves into large-scale U.S. Phase II testing after early Japanese trials showed it to be safe with maintained efficacy.